Pathogenic review: Damn, it feels good to be a virus

Ars Technica says Pathogenic, the new roguelite twin-stick shooter from Aberrant Labs, has quickly turned a strong premise into real traction. The game has passed 100,000 sales and is sitting at an “overwhelmingly positive” Steam rating, which is a notable result in a genre where new releases often blur together.

The core twist is the perspective shift: instead of defending the body, players take the role of the invading virus and fight through immune-system opposition. That framing gives the game a clear identity, and it seems to be doing the job both as a pitch and as a gameplay hook.

For developers, the interesting part is less the theme itself than the market response. Roguelite twin-stick shooters are crowded, but Pathogenic is showing that a concise concept, strong presentation, and immediate readability can still create momentum for an indie release.

The exact development scope and team size haven’t been disclosed here, but the early sales milestone suggests the game is resonating well beyond novelty. If you’re building in a saturated subgenre, this is a useful case study in how a memorable fantasy can help a mechanically familiar game stand out.